Kellner E M, Decatur A, Moran C P
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Mol Microbiol. 1996 Sep;21(5):913-24. doi: 10.1046/j.1365-2958.1996.461408.x.
During endospore formation in Bacillus subtilis an asymmetric division produces two cells, forespore and mother cell, which follow different developmental paths. Commitment to the forespore-specific developmental path is controlled in part by the activation of the forespore-specific RNA polymerase sigma factor, sigma F. Activity of sigma F is inhibited in the mother cell by the anti-sigma factor SpoIIAB. In the forespore, sigma F directs transcription of the structural gene for sigma G. However, sigma G does not become active until after engulfment of the forespore is complete. This sigma G activity is dependent upon the products of the spoIIIA operon. We showed that sigma G is present but mostly inactive in a spoIIIA mutant. We also demonstrated that the anti-sigma factor SpoIIAB can bind to sigma G in vitro. Moreover, a mutant form of sigma G that binds SpoIIAB inefficiently in vitro was shown to function independently of SpoIIIA during sporulation. These and previously reported results support a model in which SpoIIAB functions as an inhibitor of sigma G activity during sporulation. Therefore, we propose that the anti-sigma factor SpoIIAB antagonizes both sigma F and sigma G activities, and that this antagonism is relieved in the forespore in two stages. In the first stage, which follows septation, a SpoIIAA-dependent mechanism partially relieves SpoIIAB inhibition of sigma F activity in the forespore. In the second stage, which follows forespore engulfment, a SpoIIIA-dependent process inactivates SpoIIAB in the forespore, resulting in the activation of sigma G.
在枯草芽孢杆菌形成芽孢的过程中,一次不对称分裂产生了两个细胞,前芽孢和母细胞,它们沿着不同的发育路径发展。对前芽孢特异性发育路径的定向部分受前芽孢特异性RNA聚合酶σ因子σF激活的控制。在母细胞中,σF的活性被抗σ因子SpoIIAB抑制。在前芽孢中,σF指导σG结构基因的转录。然而,σG直到前芽孢被完全吞噬后才变得活跃。这种σG活性依赖于spoIIIA操纵子的产物。我们发现,在spoIIIA突变体中,σG存在但大多无活性。我们还证明,抗σ因子SpoIIAB在体外能与σG结合。此外,一种在体外与SpoIIAB结合效率低下的σG突变形式在芽孢形成过程中被证明能独立于SpoIIIA发挥作用。这些以及先前报道的结果支持了一个模型,即SpoIIAB在芽孢形成过程中作为σG活性的抑制剂发挥作用。因此,我们提出抗σ因子SpoIIAB拮抗σF和σG的活性,并且这种拮抗作用在前芽孢中分两个阶段解除。在第一阶段,即隔膜形成之后,一个依赖SpoIIAA的机制部分解除SpoIIAB对前芽孢中σF活性的抑制。在第二阶段,即前芽孢被吞噬之后,一个依赖SpoIIIA的过程使前芽孢中的SpoIIAB失活,从而导致σG的激活。